197 related articles for article (PubMed ID: 33250195)
1. Immunometabolism of regulatory T cells in cancer.
Galgani M; Bruzzaniti S; La Rocca C; Micillo T; de Candia P; Bifulco M; Matarese G
Mol Aspects Med; 2021 Feb; 77():100936. PubMed ID: 33250195
[TBL] [Abstract][Full Text] [Related]
2. Colorectal Cancer-Infiltrating Regulatory T Cells: Functional Heterogeneity, Metabolic Adaptation, and Therapeutic Targeting.
Aristin Revilla S; Kranenburg O; Coffer PJ
Front Immunol; 2022; 13():903564. PubMed ID: 35874729
[TBL] [Abstract][Full Text] [Related]
3. Tumor resident regulatory T cells.
Glasner A; Plitas G
Semin Immunol; 2021 Feb; 52():101476. PubMed ID: 33906820
[TBL] [Abstract][Full Text] [Related]
4. Cancer immunotherapy with check point inhibitor can cause autoimmune adverse events due to loss of Treg homeostasis.
Kumar P; Saini S; Prabhakar BS
Semin Cancer Biol; 2020 Aug; 64():29-35. PubMed ID: 30716481
[TBL] [Abstract][Full Text] [Related]
5. Immunometabolic Checkpoints of Treg Dynamics: Adaptation to Microenvironmental Opportunities and Challenges.
Pacella I; Piconese S
Front Immunol; 2019; 10():1889. PubMed ID: 31507585
[TBL] [Abstract][Full Text] [Related]
6. [The Role of Regulatory T-cells in Antitumor Immune Response].
Klabusay M
Klin Onkol; 2015; 28 Suppl 4():4S23-7. PubMed ID: 26647885
[TBL] [Abstract][Full Text] [Related]
7. T Regulatory Cells and Priming the Suppressive Tumor Microenvironment.
Paluskievicz CM; Cao X; Abdi R; Zheng P; Liu Y; Bromberg JS
Front Immunol; 2019; 10():2453. PubMed ID: 31681327
[TBL] [Abstract][Full Text] [Related]
8. TLR8-Mediated Metabolic Control of Human Treg Function: A Mechanistic Target for Cancer Immunotherapy.
Li L; Liu X; Sanders KL; Edwards JL; Ye J; Si F; Gao A; Huang L; Hsueh EC; Ford DA; Hoft DF; Peng G
Cell Metab; 2019 Jan; 29(1):103-123.e5. PubMed ID: 30344014
[TBL] [Abstract][Full Text] [Related]
9. CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors.
Wang H; Franco F; Tsui YC; Xie X; Trefny MP; Zappasodi R; Mohmood SR; Fernández-García J; Tsai CH; Schulze I; Picard F; Meylan E; Silverstein R; Goldberg I; Fendt SM; Wolchok JD; Merghoub T; Jandus C; Zippelius A; Ho PC
Nat Immunol; 2020 Mar; 21(3):298-308. PubMed ID: 32066953
[TBL] [Abstract][Full Text] [Related]
10. Molecular Markers of Regulatory T Cells in Cancer Immunotherapy with Special Focus on Acute Myeloid Leukemia (AML) - A Systematic Review.
Kaboli PJ; Zhang L; Xiang S; Shen J; Li M; Zhao Y; Wu X; Zhao Q; Zhang H; Lin L; Yin J; Wu Y; Wan L; Yi T; Li X; Cho CH; Li J; Xiao Z; Wen Q
Curr Med Chem; 2020; 27(28):4673-4698. PubMed ID: 31584362
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic alterations, clinical impact and therapeutic potential of regulatory T cells in cancer.
Chaudhary B; Abd Al Samid M; al-Ramadi BK; Elkord E
Expert Opin Biol Ther; 2014 Jul; 14(7):931-45. PubMed ID: 24661020
[TBL] [Abstract][Full Text] [Related]
12. Treg Cells Promote the SREBP1-Dependent Metabolic Fitness of Tumor-Promoting Macrophages via Repression of CD8
Liu C; Chikina M; Deshpande R; Menk AV; Wang T; Tabib T; Brunazzi EA; Vignali KM; Sun M; Stolz DB; Lafyatis RA; Chen W; Delgoffe GM; Workman CJ; Wendell SG; Vignali DAA
Immunity; 2019 Aug; 51(2):381-397.e6. PubMed ID: 31350177
[TBL] [Abstract][Full Text] [Related]
13. Targeting regulatory T cells in tumors.
Liu C; Workman CJ; Vignali DA
FEBS J; 2016 Jul; 283(14):2731-48. PubMed ID: 26787424
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral regulatory T cells: markers, subsets and their impact on anti-tumor immunity.
Yano H; Andrews LP; Workman CJ; Vignali DAA
Immunology; 2019 Jul; 157(3):232-247. PubMed ID: 31087644
[TBL] [Abstract][Full Text] [Related]
15. Tumor microenvironment dictates regulatory T cell phenotype: Upregulated immune checkpoints reinforce suppressive function.
Kim HR; Park HJ; Son J; Lee JG; Chung KY; Cho NH; Shim HS; Park S; Kim G; In Yoon H; Kim HG; Jung YW; Cho BC; Park SY; Rha SY; Ha SJ
J Immunother Cancer; 2019 Dec; 7(1):339. PubMed ID: 31801611
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic nexus of T cell immunometabolism in improving transplantation immunotherapy.
Kazmi S; Khan MA; Shamma T; Altuhami A; Assiri AM; Broering DC
Int Immunopharmacol; 2022 May; 106():108621. PubMed ID: 35189469
[TBL] [Abstract][Full Text] [Related]
17. Anti-regulatory T cell vaccines in immunotherapy: focusing on FoxP3 as target.
Mousavi-Niri N; Naseroleslami M; Hadjati J
Hum Vaccin Immunother; 2019; 15(3):620-624. PubMed ID: 30633616
[TBL] [Abstract][Full Text] [Related]
18. The role of metabolism on regulatory T cell development and its impact in tumor and transplantation immunity.
Bulygin AS; Khantakova JN; Shkaruba NS; Shiku H; Sennikov SS
Front Immunol; 2022; 13():1016670. PubMed ID: 36569866
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Treg Cell Metabolism and Function in Non-Lymphoid Tissues.
Yang K
Front Immunol; 2022; 13():909705. PubMed ID: 35720275
[TBL] [Abstract][Full Text] [Related]
20. Regulatory T cells as suppressors of anti-tumor immunity: Role of metabolism.
De Rosa V; Di Rella F; Di Giacomo A; Matarese G
Cytokine Growth Factor Rev; 2017 Jun; 35():15-25. PubMed ID: 28442214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]